Castlight Health Inc (CSLT) Given Consensus Recommendation of “Buy” by Analysts

Share on StockTwits

Castlight Health Inc (NYSE:CSLT) has earned an average recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $5.56.

Several analysts have recently commented on CSLT shares. Chardan Capital cut shares of Castlight Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $6.00 to $4.80 in a research note on Tuesday, July 31st. Dougherty & Co increased their price target on shares of Castlight Health from $6.00 to $7.00 and gave the company a “buy” rating in a report on Monday, July 23rd. Cantor Fitzgerald reiterated a “buy” rating and issued a $5.00 price target on shares of Castlight Health in a report on Wednesday, April 25th. William Blair assumed coverage on shares of Castlight Health in a report on Wednesday, June 20th. They issued an “outperform” rating for the company. Finally, Zacks Investment Research upgraded shares of Castlight Health from a “sell” rating to a “hold” rating in a report on Tuesday, April 24th.

In other news, Director Seth B. Cohen sold 25,000 shares of the stock in a transaction dated Monday, July 23rd. The shares were sold at an average price of $5.47, for a total value of $136,750.00. Following the completion of the transaction, the director now owns 297,716 shares in the company, valued at approximately $1,628,506.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Seth B. Cohen sold 10,000 shares of the stock in a transaction dated Wednesday, July 11th. The shares were sold at an average price of $4.50, for a total transaction of $45,000.00. Following the completion of the transaction, the director now owns 322,226 shares of the company’s stock, valued at approximately $1,450,017. The disclosure for this sale can be found here. Insiders sold a total of 74,118 shares of company stock valued at $365,231 in the last quarter. Insiders own 22.58% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the company. Metropolitan Life Insurance Co. NY purchased a new position in shares of Castlight Health in the 2nd quarter valued at about $120,000. MetLife Investment Advisors LLC purchased a new position in Castlight Health during the 4th quarter valued at about $126,000. Allianz Asset Management GmbH purchased a new position in Castlight Health during the 1st quarter valued at about $180,000. Rhumbline Advisers increased its holdings in Castlight Health by 30.9% during the 2nd quarter. Rhumbline Advisers now owns 69,922 shares of the software maker’s stock valued at $297,000 after acquiring an additional 16,520 shares in the last quarter. Finally, Swiss National Bank increased its holdings in Castlight Health by 13.1% during the 1st quarter. Swiss National Bank now owns 122,550 shares of the software maker’s stock valued at $447,000 after acquiring an additional 14,200 shares in the last quarter. Institutional investors and hedge funds own 44.14% of the company’s stock.

Shares of CSLT stock traded up $0.15 during mid-day trading on Tuesday, hitting $3.10. The stock had a trading volume of 1,321,850 shares, compared to its average volume of 535,927. Castlight Health has a fifty-two week low of $2.65 and a fifty-two week high of $5.95. The stock has a market capitalization of $413.28 million, a PE ratio of -11.92 and a beta of 1.19. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.85 and a current ratio of 1.85.

Castlight Health (NYSE:CSLT) last released its earnings results on Monday, July 30th. The software maker reported ($0.09) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.09). Castlight Health had a negative net margin of 38.02% and a negative return on equity of 22.89%. The company had revenue of $37.70 million during the quarter, compared to analysts’ expectations of $36.85 million. During the same quarter last year, the business earned ($0.07) EPS. The business’s revenue was up 15.6% on a year-over-year basis. equities analysts forecast that Castlight Health will post -0.3 earnings per share for the current fiscal year.

About Castlight Health

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.

Recommended Story: Trading Strategy Methods and Types

Analyst Recommendations for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

ExlService Holdings, Inc.  CEO Rohit Kapoor Sells 6,400 Shares
ExlService Holdings, Inc. CEO Rohit Kapoor Sells 6,400 Shares
Jazz Pharmaceuticals PLC  CEO Bruce C. Cozadd Sells 1,300 Shares
Jazz Pharmaceuticals PLC CEO Bruce C. Cozadd Sells 1,300 Shares
Zacks: Brokerages Expect WSFS Financial Co.  Will Announce Earnings of $0.87 Per Share
Zacks: Brokerages Expect WSFS Financial Co. Will Announce Earnings of $0.87 Per Share
VersaBank  Director Patrick George Acquires 111,800 Shares of Stock
VersaBank Director Patrick George Acquires 111,800 Shares of Stock
CanWel Building Materials Group Ltd  Director Marc Seguin Acquires 10,000 Shares of Stock
CanWel Building Materials Group Ltd Director Marc Seguin Acquires 10,000 Shares of Stock
Bayerische Motoren Werke  Given a €100.00 Price Target at Jefferies Financial Group
Bayerische Motoren Werke Given a €100.00 Price Target at Jefferies Financial Group


Leave a Reply

 
© 2006-2018 Zolmax.